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In a previous study (1) of the greatly increased gonadotropic effect 
of prolan when it is combined with some component of the anterior 
hypophysis, it was pointed out that  the  hypophyseal substance in 
question could be neither the growth nor gonad-stimulating hormone. 
Indeed, at  that  time it  seemed that  this  substance had no physio- 
logical effect of its own, but was dependent upon its combination with 
prolan for the exhibition of activity.  It can now be shown that the 
substance (the so called synergic factor) exhibits peculiar gonadotropic 
effects which distinguish it from any substance hitherto isolated from 
the hypophysis.  When it is administered alone (i.e.  uncombined with 
prolan) in three daily injections with  autopsy of  the  animals at the 
end of 96 hours, it has produced little or no enlargement of the ovaries; 
yet sacrifice of the experimental animals at 36, 60 and 84 hours (Chart 
1)  shows that definite gonadotropic properties are possessed by this 
material, evidenced by slightly increased ovary weights as early as the 
36th hour after the beginning of dosage, an  effect earlier  than that 
secured by some of the most potent gonadotropic preparations known. 
For example, the remarkable gonad-stimulating hormone from preg- 
nant mare's serum produces a slower initial development of the ovary, 
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which increases rapidly  after  about 72 hours so that  the  maximum 
effect from three daily doses is produced in 96-120 hours.  Prolan is 
similar in  its  insignificant early effect on  the ovary but  the ovary 
weights plateau after 72 hours.  These types of ovarian development 
are shown graphically in  Chart 2  (a)  and the comparison of prolau, 
Q) 
'b- 
~0 
40 
30 
/  .  / 
O"  / 
20-  / 
d 
i  1012  24 
I~St 
injec~on 
\-L 
I  I  I  I  I  ]  I 
36  48  60  12  64  96  108  1~0 
Hou~,.~ 
CHART 1.  Early response of the ovary to the synergistic factor followed by 
regression within 96-120 hours.  The preparations indicated have been subjected 
to different treatments: 
Glacial acetic acid (R3521). 
........  Isoelectric precipitation (supernatant)  (R3523). 
Trypsin and erepsin digestion (R3522). 
synergic  factor,  synergic  factor  in  combination  with  prolan,  and 
pregnant mare's serum may be made. 
When the injections are continued for a total of 6 days (instead of 
the usual three day injections with autopsy at 96 hours) the deve]op- 
merit produced in the ovaries by the synergic factor does not regress 
but is maintained.  Chart 2  (b)  shows the ovarian weights produced H.  M.  EVANS,  M.  E.  SIMPSON,  AND  P.  R.  AUSTIN  547 
by this method of injection using the same gonad-stimulating sub- 
stances  as before.  In  the  cases where the synergic substance was 
injected for 6 days (twice daily, as in Chart 2 (a)), the ovary weights 
do not decrease after 72-84 hours as in the case of the three injections. 
The increased ovary weights are at first not paralleled by clear mor- 
phological  expression.  Even  though  increase  in  ovarian  weight is 
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CHART 2.  Response of the ovary to various gonadotropic hormones with (a) 
injection for 3 days (twice daily) and (b) injection continued for 6 days. 
Synergic factor (R2721). 
........  Prolan. 
Synergic factor in combination with prolan. 
Pregnant mare serum. 
noted before 36 hours, the ovary may show only a slightly increased 
vascularity.  An increase in  the number of medium sized follicles is, 
however,  usually  noted  by  24-48  hours.  Some  ovaries  show  no 
further development even by 113 hours.  This is true for example of 
the  synergic  fraction  prepared  by  trypsin  and  erepsin  digestion 548  HYPOPHYSEAL  SUBSTANCE  COMBINED  WITH  PROLAN 
(R3522) shown in Chart 1.  However, the ovaries of animals injected 
with  the  synergic  factor more frequently show by 40-84  hours  at 
least a few intermediate bodies or small and medium corpora.  Ovu- 
lation has never been noted.  Uterine development, vascularization 
and increase in size, is often observed by 24-48 hours. 
Non-Identity of the Synergic Factor with Other ttypophyseal Substances 
In 1931 Fevold, Hisaw and Leonard of Wisconsin (2) reported the 
fractionation  of  pyridine  extracts  of  the  entire  hypophysis  into 
follicle-stimulating and  luteinizing  components,  the  latter  fraction 
without detectable action on the ovary when administered alone; but 
when  combined with the  former,  it  increased markedly its  action. 
Indeed,  the whole efficacy of  unfractionated pyridine extracts  was 
again secured by recombination of the two fractions.  The recombina- 
tion phenomenon resembles so strikingly what we have described as 
the activation phenomenon resulting from  the addition of  prolan to 
some hypophyseal substance, that an examination of the two proce- 
dures  for possible  underlying identity is  important.  Furthermore, 
Leonard (3) has shown that the follicle-stimulating fraction of Fevold, 
Hisaw and Leonard (2) gave augmentation when combined with pro- 
lan.  Hisaw  and  his  collaborators  have  also  pointed  out  (4)  that 
prolan  and  their luteinizing  fraction  behave similarly in  augment- 
ing  the  action  of  the  follicle-stimulating  fraction.  In  comparing 
the properties  of  the hypophyseal synergic factor  prepared  in  this 
laboratory with the properties ascribed to the follicle-stimulating frac- 
tion (2, 5) several differences became apparent.  Firstly, the synergic 
factor given in increasing doses,  though producing definite ovarian 
development in 96 hours, does not give the large ovaries described for 
the follicle-stimulating fraction.  In Table I, it is seen that a dose of 
the synergic principle 100 times that necessary to give activation (the 
minimal effective dose) produces only moderate ovarian development. 
Secondly, the synergic factor which is very potent in its ability to 
augment  the  action  of  prolan  gives  only moderate  ovary  weights 
(Table II) when combined with the luteinizing fraction.  However, 
the foUicle-stimulating  fraction is augmented by both the luteinizing 
fraction and prolan (4), producing large ovary weight as well as high 
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Most  fractions of the synergic factor so far  obtained give some lu- 
teinization of the ovaries in 96 hours although uniform enlargement of 
the follicles to medium  sized structures  is the chief  effect.  Whether 
TABLE  I 
Gonad-Stimulating A orion of Large Doses of the Synergic Factor 
Synergic factor 
Preparation 
Aqueous  alcohol (pig) 
R2586 
Aqueous  alcohol (pig) 
R3524 
Dose 
mg. 
0.2 
0.5, 
1.3, 
1.3, 
2.7. 
6.8 
13.6 
27.3 
54.5 
Weight ¢ 
ovaries 
~ttg. 
18 
20 
25 
22 
28 
27 
26 
36 
67 
Prolan 
We~ht of  Dose  ovaries 
mg.  mg, 
13.6  43 
13.6  34 
Combination  (in vitro) 
Weight of  Activation  ovaries 
rag.  per  ce~ 
54  25 
102  126 
129  188 
107  181 
130  195 
128  197 
118  181 
131  152 
141  72 
TABLE  II 
Combination of Luteinizing  Fraction with the Synergic Factor 
Synerglc factor  Luteinizing  fraction  Combination  (in vitro] 
Preparation  Dose  Dose  Activatior 
~queous alcohol (pig) R2834, 
R3160 
A.queous alcohol  (sheep),  su- 
pematant  after  isoelectric 
precipitation R3330 
~,lkaline  extract (sheep), tryp- 
sin  and  erepsin  digested 
R3331 
~cetic  acid  powder  (sheep) 
R3332 
mg. 
2.7 
1.36 
0.27 
1.36 
13.6 
Weight of 
ovaries 
mg. 
26 
21 
17 
25 
19 
rag. 
13.6 
27.3 
27.3 
27.3 
27.3 
Weight of 
ovaries 
tttg. 
22 
23 
23 
23 
23 
Weight of 
ovaries 
trig. 
41 
94 
64 
80 
54 
~;er c~ 
36 
261 
178 
166 
125 
the  luteinization is an  inherent  property  of  the  substance,  is  due  to 
contamination  by  the  luteinizing  fraction  or  is  due  to  the  animal's 
own  hypophysis  cannot  be said at  present. 550  HYPOPHYSEAL  SUBSTANCE  COMBINED  WITH  PROLAN 
These facts clearly indicate that the synergic factor, prepared in this 
laboratory, cannot be identified with either the luteinizing or follicle- 
stimulating fractions and is actually a  third gonadotropic substance 
from the pituitary.  Indeed, it would appear that the follicle-stimu- 
lating fraction (2,  5)  is a  mixture of  the synergic factor  herein  de- 
scribed, with what has been designated as the follicle-stimulating sub- 
stance.  There is no question as to the non-identity of prolan and the 
luteinizing fraction. 
It would appear, then, that we are not justified in identifying the 
above mentioned recombination effects with our activation experiments, 
that indeed a comparison of the two experiences cannot as yet be in- 
stituted, although future research may disclose an underlying reason 
why the combinations in question should necessarily increase in each 
instance the gonadotropic effect. 
Antagonism of Gonad-Stimulating Effects by Some Hypophyseal 
Component 
Some years ago it was shown that the normal gonad-stimulating 
effect of implants of anterior hypophysis in hypophysectomized rats 
(Smith (6))  or normal immature rats (Evans and Simpson (7))  could 
be prevented by the simultaneous intraperitoneal injection of crude 
extracts  of anterior hypophysis.  Leonard  (8)  has  shown similarly 
that simultaneous injection of Van Dyke's  growth extract  effectively 
masked the action of the follicle-stimulating fraction. 
It may be noted here that the conditions employed for  obtaining 
synergism are by subcutaneous injection of the in vitro combination of 
prolan with the synergic factor.  The conditions used for demonstra- 
tion of the antagonism phenomenon were subcutaneous injection  of 
pro]an and simultaneous intraperitoneal injection of the hypophyseal 
component. 
In this investigation, the capacity of fractions containing the syn- 
ergic factor  to  decrease  the action of potent gonad-stimulators was 
determined and this property was  almost  invariably  a  concomitant 
of the synergistic activity (Table III).  However, when digestion of 
anterior lobe was carried out  (digestion with trypsin  followed by a 
short  digestion with  erepsin)  the  two  activities  were  differentially 
separated.  The synergic factor was not injured but the digested ma- H.  M.  "~.VANS~ "M'. E.  SIMPSON~  AND  P.  R.  AUSTIN  551 
terial was no longer able to influence adversely the gonadotropic effect 
of  prolan.  Similarly  an  isoelectric  precipitation  at  pH  4.4-4.6  of 
TABLE  III 
Antagonism  and  Synergism  of Prolan  and  Anterior  Hypophyseal  Fractions  with 
Subsequent Differential  Destruction of the Antagonistic  Factor 
Antagonism  phenomenon  Synergism  phenomenon 
Preparation  ~'~  ~o  i ~ 
rag.  rag.  rag.  rag.  rag, 
Aqueous alcohol (pig); control, R3116  2.7  17 13.6  43  16 
As above, pH 4.5, 70°C.,  1 hr.  27 
"  "  pH4.5,  70  °''  3 hrs.  32 
"  "  pH 8.5, 70  ° "  1 hr.  27 
"  "  pH 8.5, 70  °''  3 hrs.  35 
Aqueous alcohol (sheep); control, R2289 12.7  25 13.6  43  24 
As above, supernatant after isoelectric  1.36  20  60 
precipitation R3143 
Trypsin  and  erepsin  digest  (sheep)  1.36  19 13.6  45  46 
R3356 
~  ~  '~.~ 
o~  ~  .-  O~ 
N 
rag.  rag.  rag.  rag.  rag.  per 
ce~ff 
2.7  2513.6  43124148 
124 148 
93  86 
79 
54  8 
1.36  21 13.6  38 137'284 
0.54  13.6  43 175 280 
1.36  2513.6  31]144 ~78 
CC. 
Alkaline extract (sheep); control, R2889  1.5  913.6  30  213 2.7  63 13.6  35 178122 
).27  23  105 162 
Above solution, trypsin digested  1.5  9  24 2.7  33 
0.27  213 
Trypsin digestion followed by erepsin  1.5  12  472.7  3T 
0.2722 
143  I~ 
64 7-~ 
15359 i~ 
fractions exhibiting both phenomena left a  supematant liquor which 
was the most potent fraction in synergistic activity (Table VII)  yet 
obtained,  but  was  unable  to  decrease the  effect of prolan.  These 552  HYPOPHYSEAL  SUBSTANCE  COMBINED  WITH  PROLAN 
experiments (summarized in Table III) strongly indicate that the two 
properties are not due to the same constituent. 
The fact that these fractions contain little or no growth hormone 
and  do  not  contain  the  luteinizing  or  follicle-stimulating fractions 
would seem to eliminate the synergic material  and  these  other  sub- 
stances from consideration as the antagonist. 
TABLE  IV 
Combination of Synergic Factor with Prolan Prepared by Different Methods 
Synergic  factor 
Preparation  [ 
Aqueous alcohol (sheep) 
Aqueous alcohol (pig) 
Weight 
Dose  of 
ovaries 
mg.  mg. 
6.8  29 
2.7  17 
Preparation 
Alcohol-am- 
monia 
R2193 
Repeated  al- 
cohol  pre- 
cipitation 
R2194 
Alcohol-am- 
monia 
R2380 
Repeated  al- 
cohol  pre- 
cipitation 
R2381 
Prolan 
Dose 
mg. 
27.3 
13.6 
27.3 
27.3 
54.5 
Weight 
of 
ovaries 
f?fg. 
47 
31 
42 
35 
33 
Combination 
(in  ~ilro) 
i Weight' Activa- 
of  tion  , ovaries 
mg.  per vent 
221  281 
111  164 
165  211 
155  343 
136  312 
Optimal Conditions for the Demonstration of Synergism 
It  seemed of interest to  determine the effect of prolan  variously 
prepared on the degree of synergism obtained.  In this respect, prolan 
prepared by the alcohol-ammonia extraction method  (9)  was found 
to be much more potent than that prepared by repeated alcohol pre- 
cipitation  (see Table IV). 
In order to  determine the optimal proportions of prolan  and the 
synergic factor, a  constant amount of prolan was used in  combina- tt.  M'.  EVANS,  M'.  E.  SIMPSON,  AND  P.  R.  AUSTIN  553 
tion with varying amounts of the synergic principle and a  constant 
amount  of  the  synergic  principle  was  used  in  combination  with 
varying amounts of prolan.  The results are given in Tables I  and V. 
It is seen that for optimal augmentation between 10 and 20 times the 
TABLE  V 
Combination of Variable Amounts of Prolan  with  Constant Amounts of Synergic 
Factor 
Combination  Synergic factor  Prolan  (in  ~itro) 
Weight 
Preparation  Dose  of 
ovaries 
mg.  mg 
Aqueous alcohol (pig) R2739 
1.36  22 
2.73  25 
Aqueous alcohol (pig) R3082  2.73  21 
Weight  W~ht  Dose  of  Description  Activa- 
ovaries  of ovaries  ovaries  tion 
mg.  mg.  mg.  per cent 
0.54  26  Corpora,  33  10 
large fol- 
licles 
2.7  26  "  "  108  260 
6.8  36  "  "  114  188 
13.6  38  "  "  130  210 
27.3  38  "  "  187  345 
81.8  49  "  "  209  294 
0.54 
2.7 
6.8 
13.6 
27.3 
81.8 
0.2; 
0.5~ 
1.3¢ 
2.7~ 
6.8 
13.6 
26  "  "  44  33 
26  "  "  91  176 
36  "  "  154  258 
38  "  "  131  191 
38  "  "  158  281 
49  "  "  105  87 
15  Infantile  26  24 
29  Corpora  37  16 
32  "  60  71 
30  "  75  127 
44  Corpora,  128  172 
large fol- 
licles 
4,3  "  "  155  237 
minimal dose of prolan (gonadotropic assay) is necessary in combina- 
tion with about two to three times the minimum dose of the synergic 
factor  (activation assay).  The use of larger  doses of the  synergic 
factor is inadvisable, since the augmentation produced is not as great ~4  HYPOPHYSEAL SUBSTANCE COMBINED WITH PROLAN 
as that given by the lower doses.  This may possibly be due to the 
presence of the antagonistic substance  (vide supra)  as a  contaminant 
in the preparations  then employed. 
As to duration of the synergic experiments, Chart 2 indicates that a 
sufficient augmentation (with three injections) is obtained in 72 hours 
which is, therefore, not too early to terminate the experiment. 
Chemical Characteristics of the Synergic Factor 
The comparative stability of the synergic substance noted in  the 
previous paper  (1)  has been shown to extend over a  wide variety of 
hydrogen ion concentrations, even at slightly elevated temperatures. 
Thus in alkaline solution pH 8-12 it was stable at room temperature 
for 24 hours.  At pH 8.5 it was seriously injured in 1-3 hours at 70°C. 
but at 37°C. it was stable for 6 hours.  In acid solutions (pH 4-1) it was 
somewhat  destroyed in 24 hours at  room temperature.  At pH 4-5 
it was quite stable for 1-5 hours at 37°C., but 9 hours at pH 2 completely 
inactivated the material.  Stability to acid and alkali is illustrated in 
Tables III and VI. 
Enzymatic hydrolysis of anterior lobe material was next undertaken 
in order to remove as far as possible protein contaminants without de- 
struction of the synergic principle.  Pepsin was found to be unsatis- 
factory since the synergic factor was readily injured.  Trypsin, how- 
ever, was found to be quite advantageous since  4-5  hours  digestion 
at 37°C. hydrolyzed a  considerable portion of the protein, but did not 
affect the activity of the synergic principle.  When the tryptic diges- 
tion was followed by erepsin, though some further hydrolysis was ef- 
fected, there was little loss in activity.  The erepsin digestion was of 
value  since  the  antagonistic  factor  was  thereby  eliminated.  The 
action of various digests is shown in Table VI. 
Following tryptic and ereptic digestion, the solution could be con- 
centrated in vacuo to one-tenth the original volume and then the addi- 
tion of alcohol to a  concentration of 80 per cent precipitated the ac- 
tive material which was potent for synergism in 0.27 rag. dose (3700 
rat units per gin.).  This material gave a  positive biuret test. 
The most convenient method of preparing a  potent fraction of the 
synergic principle is the aqueous  alcohol extraction procedure previ- It.  M.  EVANS,  M.  E.  SLM~PSON, AND  P.  R.  AUSTIN  555 
ously described  (1).  The material, however, contained appreciable 
amounts of the antagonistic factor among other possible contaminants. 
Isoelectric precipitation of  impurities was efficacious  both in the 
elimination of the antagonistic factor and in producing the most potent 
TABLE  VI 
Digestion  of Sheep  Anterior Pituitary  Powder with Trypsin,  Erepsin  and  Pepsin 
Hypophyseal material  Prolan  Combination 
(in elgro ) 
Weight 
Preparation  Dose  of 
ovaries 
C¢.  rag. 
Alkaline extract,  neutralized,  frozen  (con-  2.7  63 
trol) R2798  0.27  23 
Alkaline extract (above), pH 8.5,  37°C. for  2,7  33 
4.5 hrs. with trypsin R2803  0.27  20 
Trypsin digest (above), pH 8.0, 37°C. for4  2.7  37 
hrs. with erepsin R2807  0.27  22 
Alkaline extract, pH 4.0,  37°C.  for 4.5 hrs.  2.7  23 
(control) R2811  0.27  18 
Alkaline extract, pH 4.0,  37°C.  for 4.5 hrs.  2.7  18 
with pepsin R2813  0.27  19 
Aqueous alcohol extract water solution, neu- 
tral, frozen (control) R2711 
Aqueous alcohol extract, water solution, pH 
8.5, 37°C. for 6 hrs.  (control) R2712 
Aqueous alcohol extract, water solution, pH 
8.5, 37°C. for 6 hours with trypsin R2713 
Trypsin digest (above), pH 8.0, 3 hrs. with 
erepsin R2717 
0.27  32 
We~ht  Weight Activa- 
Do~  of  of 
ovaries ovaries  t/on 
rag,  rag.  rag.  per ce~ 
13.6  32  178  181 
105  183 
13.6  32  143  204 
64  88 
13.6  32  153  200 
59  64 
13.6  32  139  276 
49 
13.6  32  46  48 
41  24 
13.6  38  140  169 
0.27  48  13.6  38  140  106 
0.27  28  13.6  38  196  808 
0.27  26  13.6  38  140  205 
fraction yet obtained.  A potent fraction of the synergic factor (con- 
taining 7300 rat units per gin.) was precipitated isoelectrically and the 
supernatant liquor contained the active material which was precipitable 556  HYPOPHYSEAL  SUBSTANCE COMBINED WITH  PROLAN 
by  alcohol.  This  material  was  potent  in  a  total  dose  of  27  gamma 
(37,000 rat units per gm.).  It still gave a  biuret test.  The biological 
assay of the active fractions described above (from digestion and from 
isoelectric precipitation)  is shown  in Table  VII. 
TABLE  VII 
Assay of Potent Fractions of the Synergistic Principle 
Combination  Synergic principle  Prolan  (in ~tro) 
Preparation  ]  Dose 
Concentrate after tryptic and  ]  1.36 
ereptic  digestion  (sheep)  ]  0.34 
R3023  0.27 
0.136 
Aqueous  alcohol  (sheep)  0.27 
R3372  [  0.136 
0.54 
Isoelectric  supernatant  from  0.011 
aqueous  alcohol  extract  0.082 
(sheep) R3500  !  0.054 
0.027 
Weight of 
ovaries 
rag. 
23 
28 
21 
19 
32 
25 
21 
20 
Dose 
~g. 
136 
13.6 
13.6 
Weight of  Weight of 
ovaries  ovaries 
mg.  rag. 
144 
31  134 
73 
46 
125 
45  114 
57 
143 
109  34  113 
73 
Activation 
per cent 
278 
252 
92 
21 
197 
187 
94 
198 
180 
906 
103 
Biological Procedures 
Unless otherwise specified  experimental groups consisted of three female rats, 
22-26 days of age at the beginning of the experiment.  Daily injections were made 
on 3 consecutive days. 
Standardization of gonadotropic substances was always made by subcutaneous 
injection.  When testing for synergism the in vitro mixture of the two components 
was likewise injected subcutaneously.  The desired amounts of prolan and synergic 
factor were dissolved in a total of 11 cc. of water; each rat received a total of 3 cc. 
of the mixture.  Parallel  tests  were always made with  each component of this 
mixture; each substance was dissolved in 11 cc. of water so that the total volume 
of liquid administered  in control experiments and in the synergism experiments 
was the same. 
In order to demonstrate antagonism, the hypophyseal fraction was always ad- 
ministered intraperitonea]ly,  and the prolan was simultaneously injected subcu- 
taneously.  Each component was dissolved in 5.5 cc. of water,  with daffy injec- H. M. EVANS~ M. E. SIMPSON, AND  P. R. AUSTIN  5,57 
tion of 0.5  cc. of each solution per rat.  In the control experiments each of the 
components used in combination was dissolved in 11  cc. of water and  1 cc. was 
iniected daily.  As in the combination experiment the prolan was injected sub- 
cutaneously and the hypophyseal component intraperitoneally. 
All experimental animals were sacrificed 96 hours after the first injection unless 
otherwise  specified.  The  ovaries were observed under  a  binocular microscope, 
then carefully dissected and weighed.  The weights of ovaries given in the tables 
are averages based on  three animals. 
Preparation of Fractions Potent in the Synergic Substance 
The aqueous alcohol extraction method previously described (1) has been found 
to be the most satisfactory method of preparing comparatively potent fractions 
of the synergic principle.  Frozen sheep anterior pituitary glands (1370 gin.) were 
ground very fine into 5000  cc. of 60 per cent alcohol.  The mixture was allowed 
to stand for 6 hours at room temperature with occasional stirring after which the 
solvent was decanted and filtered and the fluid saved (ca. 4500  cc.).  The gland 
residue was reextracted with 5000  cc. of 40 per cent alcohol for 15 hours.  The 
solvent was again decanted (ca. 4500 cc.) and the extraction repeated with 5000 
cc. of 40 per cent alcohol for 3 hours.  The combined filtrates  (14,000  cc.) were 
poured into 32,000 cc. of alcohol and a small amount of saturated alcoholic sodium 
acetate was added to precipitate the active material.  By this means there was 
obtained 6.0 gin. of a  powder, almost completely soluble in water and potent in 
0.136  rag. dose  (R3372,  Table VII). 
Isoelectric precipitation of the above product eliminated inactive material and 
other impurities.  For this procedure 1 gm. of the substance was dissolved in 100 
cc. water and the insoluble material centrifuged off.  The solution was adjusted 
to pH 4.4 and a large proportion of the material then precipitated.  The mixture 
was allowed to stand 8 hours at room temperature and the precipitate was cen- 
trifuged off.  Most of the activity was retained by the supernatant liquor which 
was poured into 500 cc. of alcohol and the active material precipitated by the addi- 
tion of a small amount of saturated alcoholic sodium acetate.  The yield was 0.16 
gin. of a powder, potent in 0.027  mg. dose (R3500, Table VII) and  giving a  posi- 
tive biuret test. 
For the study of the action of enzymes on the anterior pituitary, with particu- 
iar reference to the synergic and antagonistic principles, an  alkaline extract  of 
anterior lobe was used as stock material.  Desiccated sheep anterior hypophysis 
(20 gm.) was extracted thoroughly with 1000 cc. of dilute sodium hydroxide solu- 
tion (pH ca. 8-9) and the insoluble material centrifuged off (the yield of the insolu- 
ble fraction was 10.5 gin. and contained little of the synergic factor).  The alkaline 
solution was adjusted to neutrality and used as the starting point for the follow- 
ing digestions.  It contained about 1 per cent of the anterior lobe material. 
The digestions with trypsin were carried out by adding 1 part of trypsin (Fair- 
child Bros. and Foster) to 100 parts of anterior lobe.  The solutions were adjusted 558  HYPOPHYSEAL  SUBSTANCE COMBINED WITH PROLAN 
to pH 8.5 and kept at 37°C. throughout the digestion.  The progress of the diges- 
tion was followed by determining the change in total acidity (10, ll).  Aliquots 
of the solution were titrated at intervals with sodium  hydroxide solution  using 
thymolphthalein as the indicator.  Digestion  was found to be practically com- 
plete in 4 to 5 hours.  Since no foreign buffer was used to maintain the hydrogen 
ion concentration, the solution was readjusted to pH 8.5 every 2 hours.  The tryp- 
tic hydrolysis did not affect the synergic principle but digested much of the inac- 
tive protein present in the solution  (Table VI). 
Anterior lobe solution  digested  with  trypsin was  then subjected to digestion 
with erepsin.  Erepsin (The Arlington  Chemical Co.) was  added  in an  amount 
equal to 1 per cent of the original concentration of anterior lobe, the solution ad- 
justed to pH 8.0 and kept at 37°C. during the digestion.  There was little change 
in titratable acidity during 4 hours but biological assay of the resulting  solution 
indicated that the antagonistic factor had been destroyed with little harm to the 
synergistic principle  (Tables III and VI). 
Pepsin digestion of the alkaline extract of anterior lobe was carried out using 1 
part of pepsin (The Wilson Laboratories) to 100 parts of anterior lobe material. 
Digestion  at pH 4.0 and 37°C. completely destroyed the activity of the synergic 
principle  within 4.5 hours (Table VI). 
Solutions of the anterior hypophysis digested  with trypsin and erepsin  as de- 
scribed above gave no precipitate on addition of alcohol to 80 per cent concentra- 
tion.  The solutions were, therefore, first concentrated in vacuo  (at a water bath 
temperature of 55°C.) to  one-tenth the original  volume.  This concentrate on 
precipitation with four volumes of alcohol gave a product which was easily soluble 
in water and contained most of the activity present in the original solution.  It 
was potent in 0.136 rag. dose and gave a positive biuret test. 
SUM-MARY 
The  hypophyseal  substance--the  synergic  factor--which  gives 
increased gonadotropic effects when  combined with prolan has  been 
shown to itself possess a  definite though  slight  gonadotropic activity. 
It produces transitory follicular enlargement within 24-48 hours, which, 
however, regresses  at  once on cessation of treatment  so that by the 
end of the 4th day the ovary again approximates its infantile weight. 
The  synergic  principle  indeed  provokes  only  moderate  ovarian 
development when  administered  in  100  times  the dose necessary to 
demonstrate the activation phenomenon. 
By means  of isoelectric precipitation  or by means  of tryptic and 
ereptic  digestion,  fractions  containing  the  synergic  principle  were 
freed of many contaminants,  in particular of the antagonistic factor. 
The synergic principle has been shown to be unaffected by digestion H. ~. EVANS~ M. E. SIM:PSON~ AND  P. R. AUSTIN  ~$9 
with trypsin or trypsin followed by a short digestion with erepsin, but 
the action of pepsin inactivated the material. 
A preparation of the active  substance has  been obtained which is 
potent in a total dose of 27 gamma. 
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